↓ Skip to main content

A cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand

Overview of attention for article published in BMC Health Services Research, July 2010
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
26 Dimensions

Readers on

mendeley
89 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand
Published in
BMC Health Services Research, July 2010
DOI 10.1186/1472-6963-10-209
Pubmed ID
Authors

Pattara Leelahavarong, Usa Chaikledkaew, Suradej Hongeng, Vijj Kasemsup, Yoel Lubell, Yot Teerawattananon

Abstract

Hematopoietic stem cell transplantation (HSCT) is the only curative treatment available to severe thalassemic patients. The treatment, however, is very costly, particularly in the context of low and middle income countries, and no studies have been carried out to explore its economic justifiability. This study aimed to estimate the cost-utility of HSCT compared with blood transfusions combined with iron chelating therapy (BT-ICT) for severe thalassemia in Thailand, and to investigate the affordability of HSCT using a budget impact analysis.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 89 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Italy 1 1%
Unknown 88 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 13%
Student > Master 11 12%
Other 8 9%
Student > Bachelor 8 9%
Student > Ph. D. Student 7 8%
Other 14 16%
Unknown 29 33%
Readers by discipline Count As %
Medicine and Dentistry 24 27%
Nursing and Health Professions 8 9%
Pharmacology, Toxicology and Pharmaceutical Science 6 7%
Psychology 4 4%
Economics, Econometrics and Finance 4 4%
Other 14 16%
Unknown 29 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 February 2012.
All research outputs
#20,185,720
of 22,701,287 outputs
Outputs from BMC Health Services Research
#7,066
of 7,592 outputs
Outputs of similar age
#90,427
of 95,041 outputs
Outputs of similar age from BMC Health Services Research
#45
of 48 outputs
Altmetric has tracked 22,701,287 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,592 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.7. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 95,041 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 48 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.